Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study

We evaluated relative vaccine effectiveness (rVE) of 4- vs. 3-dose mRNA-1273 against SARS-CoV-2 infection, and COVID-19 hospitalization and death in immunocompetent adults aged ≥50 years at Kaiser Permanente Southern California. We included 178,492 individuals who received a fourth dose of mRNA-1273...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2023-06, Vol.41 (29), p.4212-4219
Hauptverfasser:	Ku, Jennifer H., Sy, Lina S., Qian, Lei, Ackerson, Bradley K., Luo, Yi, Tubert, Julia E., Lee, Gina S., Florea, Ana, Bruxvoort, Katia J., Xie, Fagen, Qiu, Sijia, Chavers, Scott, Talarico, Carla A., Tseng, Hung Fu
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Adults Aged Asymptomatic California Cohort analysis Cohort Studies COVID-19 COVID-19 - prevention & control COVID-19 infection COVID-19 vaccines death Effectiveness Electronic health records Epidemiology Ethnicity FDA approval Hospitalization Humans Immunocompetence Infections Infectious disease medicine mRNA mRNA vaccines nationalities and ethnic groups Observational studies Older people Population SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Short Communication Subgroups United States - epidemiology Vaccine efficacy vaccines Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!